Investigation and Management of Severe Neonatal Hemolytic Jaundice

Clinical Context and Diagnosis

The American Academy of Pediatrics recommends G6PD testing when total serum bilirubin (TSB) is approaching exchange levels or not responding to phototherapy, as G6PD deficiency is a critical cause of kernicterus 1, 2, 5
Newborns presenting with jaundice within the first 24 hours, severe hyperbilirubinemia, and clear hemolysis require immediate investigation for hemolytic causes, with G6PD deficiency being the most critical to identify given its association with kernicterus 1, 2, 5
G6PD deficiency occurs in 11-13% of African Americans and at higher rates in Mediterranean populations, making it a significant consideration in these populations 1, 2
The presence of severe hyperbilirubinemia (e.g., 163 mg/dL) indicates a need for urgent G6PD assessment and immediate intensive phototherapy 3, 4

Initiate intensive phototherapy immediately for bilirubin levels requiring urgent treatment, such as those approaching or exceeding exchange transfusion thresholds 3, 4
Send blood for G6PD activity as part of the initial workup for severe neonatal jaundice, alongside other critical tests like blood type, Coombs' test, complete blood count with smear, and preparation for possible exchange transfusion 1, 2, 5
The American Academy of Pediatrics guidelines support the prioritization of G6PD testing in the evaluation of severe neonatal hyperbilirubinemia, especially when TSB levels are high or not responding to phototherapy 1, 2, 5

G6PD deficiency was identified as the cause of hyperbilirubinemia in 31.5% (19 of 61) of infants who developed kernicterus, highlighting its importance in the prevention of this condition 1, 5
Reticulocyte count, albumin level, and direct/conjugated bilirubin tests are part of the additional workup based on AAP guidelines to further assess and manage neonatal jaundice 1, 2, 3, 4